Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
National Cancer Institute (NCI)
Northside Hospital, Inc.
Northside Hospital, Inc.
Case Comprehensive Cancer Center
National Cancer Institute (NCI)